ArticleCancer management and research2016
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.
Hikmat Abdel-RazeqPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.